InvestorsHub Logo
Followers 21
Posts 3579
Boards Moderated 0
Alias Born 12/18/2019

Re: SkyLimit2022 post# 633698

Sunday, 09/24/2023 3:30:40 PM

Sunday, September 24, 2023 3:30:40 PM

Post# of 713606
UCLA has already advanced DC vaccine technology beyond DCVax-L. DCVax-L is a 20 year old discover and every additional improvement makes for a better vaccine and a uniquely patentable treatment that NWBO doesn't own. UCLA and Mayo Clinic both have their own dendritic cell vaccines in clinical trials that are NOT DCVax-L. They both are manufacturing a custom formulation of their own. NWBO has no rights to the results of the NIH/UCLA SPORE Combo trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News